Verastem Profit Margin

The latest profit margin for VSTM is -391.16% as of March 2026. That compares with -620320.83% in the prior-year period — up 99.9% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Verastem's historical trend and sector peers before judging valuation or financial health.

Over the past year, VSTM's profit margin moved from -620320.83% to -391.16% — a 99.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Verastem's valuation or profitability profile.

Against Healthcare companies, VSTM currently prints -391.16% for profit margin, while the sector average sits near 15.29%. That is roughly 2657.8% below the sector mean. Large gaps often invite a closer look at Verastem's growth, margins, and balance sheet.

Profit Margin shows how effectively Verastem converts resources into returns. At -391.16%, VSTM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -620320.83% in the prior-year period — up 99.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting VSTM's profit margin (-391.16%), review year-over-year change from -620320.83%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.